おすすめの製品
包装
pkg of 5 vials (5x200µL aliquots )
濃度
≥5x108 VP/ml (via p24 Assay)
アプリケーション
CRISPR
輸送温度
dry ice
保管温度
−70°C
詳細
The 10x Compatible Human CRISPRi Kinase Phosphatase Drug Targets Kit (Druggable Genome) contains one sub-pool of the top two ranked sgRNAs per gene for increased sensitivity and includes non-targeting controls built-in. In addition, the LV15 vector has both BFP and puromycin as selection markers and an optimized scaffold with capture sequence 2 (CS2, Compatible with 10x Feature Barcode technology) for sgRNA expression and function.
Custom pools for follow-up screening or 10x Genomics Compatible CRISPR pools are also available by contacting your local sales representative.
Custom pools for follow-up screening or 10x Genomics Compatible CRISPR pools are also available by contacting your local sales representative.
アプリケーション
- Functional Genomics/Target Validation
- Focused forward genetic activation screening
- Validated positive and negative controls
- Set up and optimization of screen assay
- Creation of cell lines stably expressing KRAB-dCas9
特徴および利点
- Focus on your research, and we will generate your lentivirus screening library.
- Optimized (F+E) gRNA scaffold. (pools are gRNA-only, KRAB-dCas9 sold separately CRISPRICON or CRISPRI10X
- A total of 2,318 Human Druggable genes targeted.
- Total of 4,636 unique gRNAs (top two ranking gRNAs)
- Use puromycin and or BFP as selection markers
原理
The power of CRISPR for genome engineering, coupled with the ability to perform large-scale, whole-genome loss-of-function (LOF) screening, has allowed breakthroughs in identifying gene pathways in drug resistance and disease. CRISPR is most commonly used to create double-stranded breaks that often result in loss of gene function (CRISPR-KO). However, the full extent of CRISPR′s utility extends beyond just targeted cutting of DNA. CRISPR′s Nuclease-independent applications provide equal targeting specificity. Instead of cutting, CRISPRi allows for targeted interference of gene function by delivering transcriptional repressor domains to a specific target sequence using modified dCas9 + gRNA complexes. Gene knockdown complements CRISPR-KO and CRISPRa (activation) and has distinct advantages over existing loss-of-function strategies like RNAi. As a world leader in producing lentiviral libraries, we design and build custom pools to any specifications. With this capability, we have partnered with 10x Genomics to bring innovative pooled screening products to enable discovery at single-cell resolution
保管分類コード
10 - Combustible liquids
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
カルタヘナ法
カルタヘナ法
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
eLife, 5 (2016-11-04)
We recently found that nucleosomes directly block access of CRISPR/Cas9 to DNA (Horlbeck et al., 2016). Here, we build on this observation with a comprehensive algorithm that incorporates chromatin, position, and sequence features to accurately predict highly effective single guide
資料
CRISPR lentiviral screening libraries, partnered with 10x Genomics, offer powerful research tools for pooled screening.
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)